drugset / Trial / NCT02064621
CKD-330 Drug-Drug Interaction Study (Candesartan)
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to evaluate a pharmacokinetic drug interaction and safety of Candesartan between free combination of Candesartan and Amlodipine and Candesartan monotherapy.
Timeline
- Start
- 2014-06
- Primary completion
- 2014-08
- Completion
- 2014-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amlodipine | Other / unclassified | 10 mg | Oral |
| Subject | Candesartan | Unknown | 32 mg | Oral |